第 章

41

11
第 11 章

血液疾患

引用文献（1）Abbo AH, Lucroy MD. 2007. Assessment of anemia as an independent predictor of response to chemotherapy and survival
in dogs with lymphoma: 96 cases (1993-2006). Journal of the American Veterinary Medical Association 231:1836-1842.
（2）Adachi K, Yoshimoto A, Hasegawa T, Shimizu T, Goto Y, Makimura S. 1992. Anti-erythrocyte membrane antibodies detected
in sera of dogs naturally infected with Babesia gibsoni. The Journal of Veterinary Medical Science 54:1081-1084.
（3）Adam F, Villiers E, Watson S, Coyne K, Blackwood L. 2009. Clinical pathological and epidemiological assessment ofmorphologically and immunologically confirmed canine leukaemia. Veterinary and Comparative Oncology 7:181-195.
（4）Allison RW, Little SE. 2013. Diagnosis of rickettsial diseases in dogs and cats. Veterinary Clinical Pathology 42:127-144.
（5）Alvarez FJ, Kisseberth WC, Gallant SL, Couto CG. 2006. Dexamethasone, melphalan, actinomycin D, cytosine arabinoside(DMAC) protocol for dogs with relapsed lymphoma. Journal of Veterinary Internal Medicine 20:1178-1183.
（6）Amagai Y, Tanaka A, Matsuda A, Oida K, Jung K, Nishikawa S, Jang H, Ishizaka S, Matsuda H. 2013. Increased expression of
the antiapoptotic protein MCL1 in canine mast cell tumors. The Journal of Veterinary Medical Science 75:971-974.
（7）Anjos DSD, Costa PB, Magalhães LF, Sierra OR, Calazans SG, Fonseca-Alves CE. 2018. Hydroxyurea-induced onychomadesis
in a dog with chronic myeloid leukemia: A case report. Topics in Companion Animal Medicine 33:73-76.
（8）Aoki M, Kim T, Shimada T, Kuwamura M, Yamate J, Ohashi F. 2004. A primary hepatic plasma cell tumor in a dog. The

Journal of Veterinary Medical Science 66:445-447.
（9）Argyle DJ, Corcoran BM, Whitelaw B, Milne E, Bennett D, Argyle SA, Hodgkiss-Geere HM. 2012. Characterisation anddifferentiation potential of bone marrow derived canine mesenchymal stem cells. The Veterinary Journal. 194:361-368.
（10）Assenmacher TD, Jutkowitz LA, Koenigshof AM, de A Lucidi C, Scott MA. 2019. Clinical features of precursor-targeted
immune-mediated anemia in dogs: 66 cases (2004-2013). Journal of the American Veterinary Medical Association 255:366376.
（11）Aucoin DP, Peterson ME, Hurvitz AI, Drayer DE, Lahita RG, Quimby FW, Reidenberg MM. 1985. Propylthiouracil-induced
immune-mediated disease in the cat. Journal of Pharmacology and Experimental Therapeutics 234:13-18.
（12）Avery AC, Avery PR. 2007. Determining the significance of persistent lymphocytosis. Veterinary Clinics of North America:

Small Animal Practice 37:267-282.
（13）Azakami D, Saito A, Ochiai K, Ishiwata T, Takahashi K, Kaji N, Kaji D, Kaji N, Michishita M. 2018. Chronic basophilic
leukaemia in a dog. Journal of Comparative Pathology 166:5-8.
（14）Balog K, Huang AA, Sum SO, Moore GE, Thompson C, Scott-Moncrieff JC. 2013. A prospective randomized clinical trial ofvincristine versus human intravenous immunoglobulin for acute adjunctive management of presumptive primary immunemediated thrombocytopenia in dogs. Journal of Veterinary Internal Medicine 27:536-541.
（15）Bara JJ, Richards RG, Alini M, Stoddart MJ. 2014. Concise review: Bone marrow-derived mesenchymal stem cells change
phenotype following in vitro culture: implications for basic research and the clinic. Stem Cells Journals 32:1713-23.
（16）Barros MM, Blajchman MA, Bordin JO. 2010. Warm autoimmune hemolytic anemia: recent progress in understanding theimmunobiology and the treatment Transfusion Medicine Reviews 24:195-210.
（17）Bass MC, Schultze AE. 1998. Essential thrombocythemia in a dog: case report and literature review. Journal of theAmerican Animal Hospital Association 34:197-203.
（18）Bell TG, Butler KL, Sill HB, Stickle JE, Ramos-Vara JA, Dark MJ. 2002. Autosomal recessive severe combined
immunodeficiency of Jack Russell terriers. Journal of Veterinary Diagnostic Investigation 4:194-204.
（19）Bellezza E, Bianchini E, Pettinelli S, Angeli G, Leonardi L. 2016. Intestinal plasmacytoma causing colocolic double
intussusception in an adult dog. Journal of Small Animal Practice 57:718.
（20）Bennett JM, Catovsky D, Daniel MT, Flandrin GF, Galton DA, Gralnick HR, Sultan C. 1976. Proposals for the classification of
the acute leukemias. British Journal of Haematology 33:451-458.
（21）Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. 1982. Proposals for the classification of
the myelodysplastic syndromes. British Journal of Haematology 51:189-199.

第 章

42

11

（22）Bennett AL, Williams LE, Ferguson MW, Hauck ML, Suter SE, Lanier CB, Hess PR. 2017. Canine acute leukaemia: 50
cases(1989-2014). Veterinary and Comparative Oncology 15:1101-1114.
（23）Berentsen S, Sundic T. 2015. Red blood cell destruction in autoimmune hemolytic anemia: role of complement andpotential new targets for therapy. BioMed Research International 363278.
（24）Bianco D, Armstrong PJ, Washabau RJ. 2008. Presumed primary immune-mediated thrombocytopenia in four cats. Journalof Feline Medicine and Surgery 10:496-500.
（25）Bianco D, Armstrong PJ, Washabau RJ. 2009. A prospective, randomized, double-blinded, placebo-controlled
study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediatedthrombocytopenia in dogs. Journal of Veterinary Internal Medicine 23:1071-1078.
（26）Black V, Adamantos S, Barfield D, Tasker S. 2016. Feline non-regenerative immune-mediated anaemia: features andoutcome in 15 cases. Journal of Feline Medicine and Surgery 18:597-602.
（27）Bloom JC, Thiem PA, Sellers TS, Lewis HB, Deldar A. 1988. Cephalosporin induced immune cytopenia in the dog:
demonstration of erythrocyte-, neutrophil-, and platelet-associated IgG following treatment with cefazedone. American

Journal of Hematology 28:71-78.
（28）Boostrom BO, Moore AS, DeRegis CJ, Robat C, Freeman K, Thamm DH. 2017. Canine cutaneous plasmacytosis: 21 cases(2005-2015). Journal of Veterinary Internal Medicine 31:1074-1080.
（29）Borgatti A. 2010. Plasma cell tumor. Veterinary Hematology (Wiess DJ, Wardrop KJ eds), 511-519, Willy -Blackwell.
（30）Breen M. 2009. Update on genomics in veterinary oncology. Topics in Companion Animal Medicine 24:113-121.
（31）Breuer W, Hermanns W, Thiele J. 1999. Myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML) and chronic
myeloproliferative disorder (CMPD) in cats. Journal of Comparative Pathology 121:203-216.
（32）Bromberek JL, Rout ED, Agnew MR, Yoshimoto J, Morley PS, Avery AC. 2016. Breed distribution and clinical characteristics
of B cell chronic lymphocytic leukemia in dogs. Journal of Veterinary Internal Medicine 30:215-222.
（33）Bronzini I, Aresu L, Paganin M, Marchioretto L, Comazzi S, Cian F, Riondato F, Marconato L, Martini V, Kronnie GT. 2017.
DNA methylation and targeted sequencing of methyltransferases family genes in canine acute myeloid leukaemia, modellinghuman myeloid leukaemia. Veterinary and Comparative Oncology 15:910-918.
（34）Brown CD, Parnell NK, Schulman RL, Brown CG, Glickman NW, Glickman L. 2006. Evaluation of clinicopathologic features,
response to treatment, and risk factors associated with idiopathic neutropenia in dogs: 11 cases (1990-2002). Journal of theAmerican Veterinary Medical Association 229:87-91.
（35）Brown MR, Rogers KS. 2001. Neutropenia in dogs and cats: a retrospective study of 261 cases. Journal of the American

Animal Hospital Association 37:131-139.
（36）Burgess K, Moore A, Rand W, Cotter SM. 2000. Treatment of immune-mediated hemolytic anemia in dogs withcyclophosphamide. Journal of Veterinary Internal Medicine 14:456-462.
（37）Burnett RC, Vernau W, Modiano JF, Olver CS, Moore PF, Avery AC. 2003. Diagnosis of canine lymphoid neoplasia using
clonal rearrangements of antigen receptor genes. Veterinary Pathology 40:32-41.
（38）Caldin M, Campigli M, Zoia A, Zanella A, Bertolini G, Furlanello T, Lubas G. 2019. Bleeding diathesis in canine multiple
myeloma and prognostic implications: A cohort study in 156 dogs. Research in Veterinary Science 125:305-308.
（39）Cannon C, Borgatti A, Henson M, Husbands B. 2015. Evaluation of a combination chemotherapy protocol including
lomustine and doxorubicin in canine histiocytic sarcoma. Journal of Small Animal Practice 56:425-429.
（40）Cannon CM, Knudson C, Borgatti A. 2015. Clinical signs, treatment, and outcome in cats with myeloma-related disorder
receiving systemic therapy. Journal of the American Animal Hospital Association 51:239-248.
（41）Carr AP, Panciera DL, Kidd L. 2002. Prognostic factors for mortality and thromboembolism in canine immune-mediatedhemolytic anemia: a retrospective study of 72 dogs. Journal of Veterinary Internal Medicine 16:504-509.
（42）Caviezel LL, Raj K, Giger U. 2014. Comparison of 4 direct Coombs’ test methods with polyclonal antiglobulins in anemic
and nonanemic dogs for in-clinic or laboratory use. Journal of Veterinary Internal Medicine 28:583-591.
（43）Chalhoub S, Langston CE. Farrelly J. 2012. The use of darbepoetin to stimulate erythropoiesis in anemia of chronic kidney

第 章

43

11
disease in cats: 25 cases. Journal of Veterinary Internal Medicine 26:363-369.
（44）Chung CY, Ysebaert D, Berneman ZN, Cools N. 2013. Dendritic cells: cellular mediators for immunological tolerance.

Clinical and Developmental Immunology 972865.
（45）Comazzi S, Riondato F. 2021. Flow cytometry in the diagnosis of canine T-cell lymphoma. Frontiers in - Veterinary Science
8:600963.
（46）Comazzi S, Gelain ME, Martini V, Riondato F, Miniscalco B, Marconato L, Stefanello D, Mortarino M. 2011.
Immunophenotype predicts survival time in dogs with chronic lymphocytic leukemia. Journal of Veterinary Internal

Medicine 25:100-106.
（47）Cooper SA, Huang AA, Raskin RE, Weng HY, Scott-Moncrieff JC. 2016. Clinical data, clinicopathologic findings andoutcome in dogs with amegakaryocytic thrombocytopenia and primary immune-mediated thrombocytopenia. Journal of

Small Animal Practice 57:142-147.
（48）Cowgill LD, James KM, Levy JK, Browne JK, Miller A, Lobingier RT, Egrie JC. 1998. Use of recombinant humanerythropoietin for management of anemia in dogs and cats with renal failure. Journal of the American Veterinary Medical
Association 212:521-528.
（49）Danova NA, Robles-Emanuelli JC, Bjorling DE. 2006. Surgical excision of primary canine rectal tumors by an anal approachin twenty-three dogs. Veterinary Surgery 35:337-340.
（50）Davis LL, Hume KR, Stokol T. 2018. A retrospective review of acute myeloid leukaemia in 35 dogs diagnosed by a
combination of morphologic findings, flow cytometric immunophenotyping and cytochemical staining results (2007-2015).

Veterinary and Comparative Oncology 16:268-275.
（51）Degen MA, Feldman BF, Turrel JM, Goding B, Kitchell B, Mandell CP. 1989. Thrombocytosis associated with amyeloproliferative disorder in a dog. Journal of the American Veterinary Medical Association 194:1457-1459.
（52）deLaforcade A, Bacek L, Blais MC, Goggs R, Lynch A, Rozanski E. 2019. Consensus on the rational use of antithrombotics
in veterinary critical care (CURATIVE): domain 1-defining populations at risk. Journal of Veterinary Emergency and Critical

Care (San Antonio). 29:37-48.
（53）Devine L, Armstrong PJ, Whittemore JC, Sharkey L, Bailiff N, Huang A, Rishniw M. 2017. Presumed primary immunemediated neutropenia in 35 dogs: a retrospective study. Journal of Small Animal Practice 58:307-313.
（54）Dircks BH, Schuberth HJ, Mischke R. 2009. Underlying diseases and clinicopathologic variables of thrombocytopenic dogs
with and without platelet-bound antibodies detected by use of a flow cytometric assay: 83 cases (2004-2006). Journal of theAmerican Veterinary Medical Association 235:960-966.
（55）Dobson J, Villiers E, Morris J. 2006. Diagnosis and management of leukemia in dogs and cats. In Practice 28:22-31.
（56）Dorn CR, Taylor DO, Frye FL, Hibbard HH. 1968. Survey of animal neoplasms in Alameda and Contra Costa Couties,
California. I. Methodology and description of cases. Journal of the National Cancer Institute 40:295-305.
（57）eClinPath: Cornell University Veterinary Clinical Pathology website.
http://eclinpath.com（58）Edamura K, Kuriyama K, Kato K, Nakano R, Teshima K, Asano K, Sato T, Tanaka S. 2012. Proliferation capacity, neuronaldifferentiation potency and microstructures after the differentiation of canine bone marrow stromal cells into neurons. The

Journal of Veterinary Medical Science 74:923-927.
（59）Edwards DS, Henley WE, Harding EF, Harding EF, Dobson JM, Wood JLN. 2003. Breed incidence of lymphoma in a UK
population of insured dogs. Veterinary and Comparative Oncology 1:200-206.
（60）Elliott J. 2018. Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flatcoated Retrievers. Australian Veterinary Journal 96:502-507.
（61）Essex MFD. 1976. The risk to humans from malignant diseases of their pets: an unsettled issue. Journal of the American

Animal Hospital Association 12:386-390.
（62）Feldman BF, Handagama P, Lubberink AA. 1985. Splenectomy as adjunctive therapy for immune-mediatedthrombocytopenia and hemolytic anemia in the dog. Journal of the American Veterinary Medical Association 187:617-619.

第 章

44

11

（63）Feldman BF, Thomason KJ, Jain NC. 1988. Quantitative platelet disorders. Veterinary Clinics of North America: Small

Animal Practice 18:35-49.
（64）Fernandez R, Chon E. 2018. Comparison of two melphalan protocols and evaluation of outcome and prognostic factors in
multiple myeloma in dogs. Journal of Veterinary Internal Medicine 32:1060-1069.
（65）Fernández R, Chon E. 2018. Comparison of two melphalan protocols and evaluation of outcome and prognostic factors in
multiple myeloma in dogs. Journal of Veterinary Internal Medicine 32:1060-1069.
（66）Fine DM, Tvedten HW. 1999. Chronic granulocytic leukemia in a dog. Journal of the American Veterinary Medical
Association 214:1809-1812.
（67）Fiocchi EH, Cowgill LD, Brown DC, Markovich JE, Tucker S, Labato MA, Callan MB. 2017. The use of darbepoetin tostimulate erythropoiesis in the treatment of anemia of chronic kidney disease in dogs. Journal of Veterinary Internal

Medicine 31:476-485.
（68）Flood-Knapik KE, Durham AC, Gregor TP, Sánchez MD, Durney ME, Sorenmo KU. 2013. Clinical, histopathological andimmunohistochemical characterization of canine indolent lymphoma. Veterinary and Comparative Oncology 11:272-286.
（69）Foale RD, Herrtage ME, Day MJ. 2003. Retrospective study of 25 young weimaraners with low serum immunoglobulin
concentrations and inflammatory disease. Veterinary Record 153:553-558.
（70）Fournel-Fleury C, Mangol JP, Bricaire P, Marchal T, Chabanne L, Delverdier A, Bryon PA, Felman P. 1997. Cytological andimmunological classification of canine malignant lymphomas: Comparison with human non-Hodgkin’s lymphomas. The

Journal of Pathology 117:35-59.
（71）Fujino Y, Sawamura S, Kurakawa N, Hisasue M, Masuda K, Ohno K, Tsujimoto H. 2004. Treatment of chronic lymphocytic
leukaemia in three dogs with melphalan and prednisolone. Journal of Small Animal Practice 45:298-303.
（72）Fujiwara-Igarashi A, Goto-Koshino Y, Mochizuki H, Sato M, Fujino Y, Ohno K, Tsujimoto H. 2014. Inhibition of p16 tumor
suppressor gene expression via promoter hypermethylation in canine lymphoid tumor cells. Research in Veterinary Science
97:60-63.
（73）Furman E, Leidinger E, Hooijberg EH, Bauer N, Beddies G, Moritz A. 2014. A retrospective study of 1,098 blood samples
with anemia from adult cats: frequency, classification, and association with serum creatinine concentration. Journal of

Veterinary Internal Medicine 28:1391-1397.
（74）
Garden OA, Kidd L, Mexas AM, Chang YM, Jeffery U, Blois SL, Fogle JE, MacNeill AL, Lubas G, Birkenheuer A, Buoncompagni S,
Dandrieux JRS, Di Loria A, Fellman CL, Glanemann B, Goggs R, Granick JL, LeVine DN, Sharp CR, Smith-Carr S, Swann JW,
Szladovits B. 2019. ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats.

Journal of Veterinary Internal Medicine 33:313-334.
（75）Garrett LD, Thamm DH, Chun R, Dudley R, Vail DM. 2002. Evaluation of a 6-month chemotherapy protocol with nomaintenance therapy for dogs with lymphoma. Journal of Veterinary Internal Medicine 16:704-709.
（76）Gasper PW, Rosen DK, Fulton R. 1996. Allobeneic marrow transplantaium in a cat with acute myeloid leukemia. Journal of

the American Veterinary Medical Association 208:1280-1284.
（77）Goggs R, Blais MC, Brainard BM, Chan DL, deLaforcade AM, Rozanski E, Sharp CR. 2019. American College of Veterinary
Emergency and Critical Care (ACVECC) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care
(CURATIVE) guidelines: Small animal. Journal of Veterinary Emergency and Critical Care (San Antonio) 29:12-36.
（78）Gouldin ED, Mullin C, Morges M, Mehler SJ, de Lorimier L-P, Oakley C, Risbon R, May L, Kahn SA, Clifford C. 2017. Feline
discrete high-grade gastrointestinal lymphoma treated with surgical resection and adjuvant CHOP-based chemotherapy:
retrospective study of 20 cases. Veterinary and Comparative Oncology 15:328-335.
（79）Gustafson TL, Villamil A, Taylor BE, Flory A. 2014. A retrospective study of feline gastric lymphoma in 16 chemotherapytreated cats. Journal of the American Animal Hospital Association 50:46-52.
（80）Harvey JW. 2012. Disorders of Bone Marrow. Veterinary Hematology A Diagnostic Guide and Color Atlas (Harvey JW ed.),260-327, Elsevier Saunders.
（81）Hall AM, Vickers MA, McLeod E, Barker RN. 2005. Rh autoantigen presentation to helper T cells in chronic lymphocytic

第 章

45

11
leukemia by malignant B cells. Blood 105:2007-2015.
（82）Hammond WP, Csiba E, Canin A, Hockman H, Souza LM, Layton JE, Dale DC. 1991. Chronic neutropenia. A new canine
model induced by human granulocyte colony-stimulating factor. Journal of Clinical Investigation 87:704-710.
（83）Haney M, Beaver L, Turrel J, Clifford CA, Klein MK, Crawford S, Poulson JM, Azuma C. 2009. Survival analysis of 97
cats with nasal lymphoma: a multi-institutional retrospective study (1986-2006). Journal of Veterinary Internal Medicine
23:287-294.
（84）Harvey JW. 1981. Myeloproliferative disorders in dogs and cats. Veterinary Clinics of North America: Small Animal

Practice 11:349-381.
（85）Helmond SE, Polzin DJ, Armstrong PJ, Finke M, Smith SA. 2010. Treatment of immune-mediated hemolytic anemia withindividually adjusted heparin dosing in dogs. Journal of Veterinary Internal Medicine 24:597-605.
（86）廣田好和．1996. 自己免疫病（自己免疫の発生と臨床）動物の免疫学，動物の免疫学（小沼 操 , 小野寺 節 , 山内一也 編），
200-212，文永堂出版．
（87）Hisasue M, Nagashima N, Nishigaki K, Fukuzawa I, Ura S, Katae H, Tsuchiya R, Yamada T, Hasegawa A, Tsujimoto H. 2009.
Myelodysplastic syndromes and acute myeloid leukemia in cats infected with feline leukemia virus clone33 containing aunique long terminal repeat. International Journal of Cancer 124:1133-1141.
（88）Hisasue M, Nishigaki K, Katae H, Yuri K, Mizuno T, Fujino Y, Setoguchi A, Hasegawa A, Watari T, Masuda K, Ohno K,
Tsujimoto H. 2000. Clonality analysis of various hematopoietic disorders in cats naturally infected with feline leukemia
virus. The Journal of Veterinary Medical Science 62:1059-1065.
（89）Hisasue M, Tanaka M, Neo S. 2022. A cat with myelodysplastic syndrome by administration of the methylation inhibitor
Azacytidine. The Journal of Veterinary Medical Science 84:142-148.
（90）Hodges J, Christopher MM. 2011. Diagnostic accuracy of using erythrocyte indices and polychromasia to identify
regenerative anemia in dogs. Journal of the American Veterinary Medical Association 238:1452-1458.
（91）Hoff B, Lumsden JH, Valli VE, Kruth SA. 1991. Myelofibrosis: Review of clinical and pathological features in fourteen dogs.

The Canadian Veterinary Journal 32:357-361.
（92）Horgan JE, Roberts BK, Schermerhorn T. 2009. Splenectomy as an adjunctive treatment for dogs with immune-mediatedhemolytic anemia: ten cases (2003-2006). Journal of Veterinary Emergency and Critical Care 19:254-261.
（93）Hosoya K, Kisseberth WC, Lord LK, Alvarez FJ, Lara-Garcia A, Kosarek CE, London CA, Couto CG. 2007. Comparson of
COAP and UW-19 protocols for dogs with multicentric lymphoma. Journal of Veterinary Internal Medicine 21:1355-1363.
（94）Jain NC, Blue JT, Grindem CB, Harvey JW, Kociba GJ, Krehbiel JD, Latimer KS, Raskin RE, Thrall MA, Zinkl JG. 1991.
Proposed criteria for classification of acute myeloid leukemia in dogs and cats. Veterinary Clinical Pathology 20:63-82.
（95）Jonas LD, Thrall MA, Weiser MG. 1987. Nonregenerative form of immune-mediated hemolytic anemia in dogs. Journal of

the American Animal Hospital Association 23:201-204.
（96）Kagawa Y, Nakano Y, Kobayashi T, Asano K, Takagi S. 2016. Localized pulmonary histiocytic sarcomas in Pembroke Welsh
Corgi. The Journal of Veterinary Medical Science 77:1659-1661.
（97）Kamishina H, Farese JP, Storm JA, Cheeseman JA, Clemmons RM. 2008. The frequency, growth kinetics, and osteogenic/
adipogenic differentiation properties of canine bone marrow stromal cells. In Vitro Cellular & Developmental Biology-

Animal 44:472-479.
（98）
Kato D, Takahashi M, Yonezawa T, Ohmi A, Takeda S, Nakagawa T, Hosoda S, Kanemoto H, Fukushima K, Ohno K, Matsuki N,
Tsujimoto H. 2020. Evaluation of an automated point-of-care test system for measuring thrombin-antithrombin complex indogs. Journal of Veterinary Emergency and Critical Care (San Antonio) 30:102-106.
（99）Keller SM, Vernau W, Moore PF. 2016. Clonality testing in veterinary medicine: a review with diagnostic guidelines.
Veterinary Pathology 53:711-725.
（100）Kezer KA, Barber LG, Jennings SH. 2018. Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs.

Veterinary and Comparative Oncology 16:77-80.
（101）Kidd L, Mackman N. 2013. Prothrombotic mechanisms and anticoagulant therapy in dogs with immune-mediated

第 章

46

11

hemolytic anemia. Journal of Veterinary Emergency and Critical Care (San Antonio) 23:3-13.
（102）Kiselow MA, Rassnick KM, McDonough SP, Goldstein RE, Simpson KW, Weinkle TK, Erb HN. 2008. Outcome of cats with
low-grade lymphocytic lymphoma: 41 cases (1995-2005). Journal of the American Veterinary Medical Association 232:405410.
（103）Kiupel M, Smedley RC, Pfent C, Xie Y, Xue Y, Wise AG, DeVaul JM, Maes RK. 2011. Diagnostic algorithm to differentiate
lymphoma from inflammation in feline small intestinal biopsy samples. Veterinary Pathology 48:212-222.
（104）木崎昌弘 編．2017. メディカルスタッフのための白血病診療ハンドブック，中外医学社．
（105）Kjelgaard-Hansen M, Goggs R, Wiinberg B, Chan DL. 2011. Use of serum concentrations of interleukin-18 and monocyte
chemoattractant protein-1 as prognostic indicators in primary immune-mediated hemolytic anemia in dogs. Journal of

Veterinary Internal Medicine 25:76- 82.
（106）Kohn B, Weingart C, Eckmann V, Ottenjann M, Leibold W. 2006. Primary immune-mediated hemolytic anemia in 19 cats:diagnosis, therapy, and outcome (1998-2004). Journal of Veterinary Internal Medicine 20:159-166.
（107）Koshino A, Goto-Koshino Y, Setoguchi A, Ohno K, Tsujimoto H. 2016. Mutation of p53 gene and its correlation with theclinical outcome in dogs with lymphoma. Journal of Veterinary Internal Medicine 30:223-229.
（108）Krick EL, Little L, Patel R, Shofer FS, Sorenmo K, Clifford CA, Baez JL. 2008. Description of clinical and pathologicalfindings, treatment and outcome of feline large granular lymphocyte lymphoma (1996-2004). Veterinary and Comparative

Oncology 6:102-110.
（109）Kristensen AT, Klausner JS, Weiss DJ, Schultz RD, Bell FW. 1991. Spurious hyperphosphatemia in a dog with chronic
lymphocytic leukemia and an IgM monoclonal gammopathy. Veterinary Clinical Pathology 20:45-48.
（110）Lachowicz JL, Post GS, Moroff SD, Mooney SC. 2004. Acquired amegakaryocytic thrombocytopenia － four cases and aliterature review. The Journal of Small Animal Practice 45:507 -514.
（111）Latimer KS, Duncan JR, Kircher IM. 1987. Nuclear segmentation, ultrastructure, and cytochemistry of blood cells fromdogs with Pelger-Huët anomaly. Journal of Comparative Pathology 97:61-72.
（112）Leifer CE, Matus RE, Patnaik AK, MacEwen EG. 1983. Chronic myelogenous leukemia in the dog. Journal of the American
Veterinary Medical Association 183:686-689.
（113）Levy LS. 2008. Advances in understanding molecular determinants in FeLV pathology. Veterinary Immunology and

Immunopathology 123:14-22.
（114）Liddle CG, Putnam JP, Berman E, Fisher H, Ostby J. 1984. A comparison of chromium-51 and iron-59 for estimating
erythrocyte survival in the cat. Laboratory Animal Science 34:365-370.
（115）Lingard AE, Briscoe K, Beatty JA, Moore AS, Crowley AM, Krockenberger M, Churcher RK, Canfield PJ, Barrs VR. 2009.
Low-grade alimentary lymphoma: clinicopathological findings and response to treatment in 17 cases. Journal of Feline

Medicine and Surgery 11:692-700.
（116）Little SE. 2010. Ehrlichiosis and anaplasmosis in dogs and cats. Veterinary Clinics of North America: Small Animal

Practice 40:1121-1140.
（117）Lobetti RG, Leisewitz AL, Spencer JA. 1996. Pneumocystis carinii in the miniature dachshund: case report and literature
review. Journal of Small Animal Practice 37:280-285.
（118）Louwerens M, London CA, Pedersen NC, Lyons LA. 2005. Feline lymphoma in the post-feline leukemia virus era. Journalof Veterinary Internal Medicine 19:329-335.
（119）Lucidi CA, de Rezende CLE, Jutkowitz LA, Scott MA. 2017. Histologic and cytologic bone marrow findings in dogs withsuspected precursor-targeted immune-mediated anemia and associated phagocytosis of erythroid precursors. Veterinary
Clinical Pathology 46:401-415.
（120）MacEwen EG, Brown NO, Patnaik AK, Hayes AA, Passe S. 1981. Cyclic combination chemotherapy of canine
lymphosarcoma. Journal of the American Veterinary Medical Association 178:1178-1181.
（121）Mason SL, Finotello R, Blackwood L.2018. Epirubicin in the treatment of canine histiocytic sarcoma: sequential,
alternating and rescue chemotherapy. Veterinary and Comparative Oncology 16:E30-E37.

第 章

47

11
（122）Matsumoto I, Nakashima K, Goto-Koshino Y, Chambers JK, Tsujimoto H, Nakayama H, Uchida K. 2019.
Immunohistochemical profiling of canine intestinal T-cell lymphomas. Veterinary Pathology 56:50-60.
（123）Matus RE, Leifer CE, MacEwen EG. 1983. Acute lymphoblastic leukemia in the dog: a review of 30 cases. Journal of theAmerican Veterinary Medical Association 183:859-862.
（124）McLewee N, Archer T, Wills R, Mackin A, Thomason J. 2018. Effects of aspirin dose escalation on platelet function andurinary thromboxane and prostacyclin levels in normal dogs. Journal of Veterinary Pharmacology and Therapeutics 41:6067.
（125）McLewee N, Archer T, Wills R, Mackin A, Thomason J. 2018. Effects of aspirin dose escalation on platelet function andurinary thromboxane and prostacyclin levels in normal dogs. Journal of Veterinary Pharmacology and Therapeutics 41:6067.
（126）McManus PM. 2005. Classification of myeloid neoplasms: A comparative review. Veterinary Clinical Pathology 34:189210.
（127）Medway W, Rapp JP. 1962. A case of chronic granulocytic leukemia with thrombocytopenic purpura in a dog. The

Cornell Veterinarian 52:247-260.
（128）Meier VS, Beatrice L, Turek M, Poirier VJ, Cancedda S, Stiborova K, Körner M, Marconato L, Weyland MS, Bley CR. 2019.
Outcome and failure patterns of localized sinonasal lymphoma in cats treated with first-line single-modality radiation
therapy: a retrospective study. Veterinary and Comparative Oncology 17:528-536.
（129）Mellor PJ, Haugland S, Smith KC, Powell RM, Archer J, Scase TJ, Villiers EJ, McNeil PE, Nixon C, Knott C, Fournier D,
Murphy S, Polton GA, Belford C, Philbey AW, Argyle DJ, Herrtage ME, Day MJ. 2008. Histopathologic, immunohistochemical,
and cytologic analysis of feline myeloma-related disorders: further evidence for primary extramedullary development in thecat. Veterinary Pathology 45:159-173.
（130）Miller SA, Hohenhaus AE, Hale AS. 2004. Case-control study of blood type, breed, sex, and bacteremia in dogs withimmune-mediated hemolytic anemia. Journal of the American Veterinary Medical Association 224:232-235.
（131）Mizukoshi T, Fujino Y, Yasukawa K, Matumoto H, Matsumura S, Nagasaki T, Ohno K, Tsujimoto H, Shimoda T. 2006.
Essential thrombocythemia in a dog. The Journal of Veterinary Medical Science 68:1203-1206.
（132）Mizutani N, Goto-Koshino Y, Takahashi M, Uchida K, Tsujimoto H. 2016. Clinical and histopathological evaluation of 16
dogs with T-zone lymphoma. The Journal of Veterinary Medical Science 78:1237-1244.
（133）Mochizuki H, Nakamura K, Sato H, Takahashi M, Fujino Y, Ohno K, Uchida K, Nakayama H, Tsujimoto H. 2011. Multiplex
PCR and Genescan analysis to detect immunoglobulin heavy chain gene rearrangement in feline B-cell neoplasms.

Veterinary Immunology and Immunopathology 143:38-45.
（134）Mochizuki H, Nakamura K, Sato H, Takahashi M, Fukushima K, Ko Nakashima K, Fujino Y, Ohno K, Uchida K, Nakayama
H, Tsujimoto H. 2012. GeneScan analysis to detect clonality of T-cell receptor γ gene rearrangement in feline lymphoidneoplasms. Veterinary Immunology and Immunopathology 145:402-409.
（135）Mochizuki H, Goto-Koshino Y, Takahashi M, Fujino Y, Ohno K, Tsujimoto H. 2012. X-chromosome inactivation patternanalysis for the assessment of cell clonality in cats. Veterinary Pathology 49:963-970.
（136）Mochizuki H, Goto-Koshino Y, Takahashi M, Fujino Y, Ohno K, Tsujimoto H. 2015. Demonstration of the cell clonality incanine hematopoietic tumors by X-chromosome inactivation pattern analysis. Veterinary Pathology 52:61-69.
（137）Moore PF. 2014. A review of histiocytic diseases of dogs and cats. Veterinary Pathology 51:167-184.
（138）Moore PF, Rodriguez-Bertos A, Kass PH. 2012. Feline gastrointestinal lymphoma: mucosal architecture,
immunophenotype, and molecular clonality. Veterinary Pathology 49:658-668.
（139）Moore PF, Rosin A. 1986. Malignant histiocytosis of Bernese mountain dogs. Veterinary Pathology 23:1-10.
（140）Morishita K, Takeuchi K, Mori S, Hayakawa S, Nakamura K, Sasaki N, Ohta H, Takiguchi M. 2016. Prospective study in thetreatment of nonregenerative immune-mediated anemia in 8 dogs. Journal of Veterinary Internal Medicine 30:1470.
（141）Murata H, Shimada N, Yoshioka M. 2004. Current research on acute phase proteins in veterinary diagnosis: an overview,

The Veterinary Journal 168:28-40.

第 章

48

11

（142）Mylonakis ME, Koutinas AF, Billinis C, Leontides LS, Kontos V, Papadopoulos O, Rallis T, Fytianou A. 2003. Evaluationof cytology in the diagnosis of acute canine monocytic ehrlichiosis (Ehrlichia canis ): a comparison between five methods.

Veterinary Microbiology 91:197-204.
（143）Nagashima N, Hisasue M, Higashi K, Kano R, Tsujimoto H, Hasegawa A. 2001. Bone marrow colony-forming unit assay incats with naturally occurring myelodysplastic syndromes. International Journal of Hematology 73:453-456.
（144）Nakamura M, Takahashi M, Ohno K, Koshino A, Nakashima K, Setoguchi A. Fujino Y, Tsujimoto H. 2008. C-reactive
protein concentration in dogs with various diseases. Journal of Veterinary Medical Science 70:127-131.
（145）Neil JC, Hughes D, McFarlane R, Wilkie NM, Onions DE, Lees G, Jarrett O. 1984. Transduction and rearrangement of the
myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature 308:814-820.
（146）Neo S, Ishikawa T, Ogiwara K, Kansaku N, Nakamura M, Watanabe M, Hisasue M, Tsuchiya R, Yamada T. 2009. Canine
bone marrow cells differentiate into hepatocyte-like cells and placental hydrolysate is a potential inducer. Research in

Veterinary Science . 87:1-6.
（147）Nishimura T, Hatoya S, Kanegi R, Sugiura K, Wijewardana V, Kuwamura M, Tanaka M, Yamate J, Izawa T, Takahashi M,
Kawate N, Tamada H, Imai H, Inaba T. 2013. Generation of functional platelets from canine induced pluripotent stem cells.

Stem Cells and Development 22:2026-2035.
（148）Novacco M, Comazzi S, Marconato L, Cozzi M, Stefanello D, Aresu L, Martini V. 2016. Prognostic factors in canine acuteleukaemias: a retrospective study. Veterinary and Comparative Oncology 14:409-416.
（149）Novinger MS, Sullivan PS, McDonald TP. 1996. Determination of the lifespan of erythrocytes from greyhounds, using an
in vitro biotinylation technique. American Journal of Veterinary Research 57:739-742.
（150）O’Brien D, Moore PF, Vernau W, Peauroi JR, Rebhun RB, Rodriguez Jr CO, Skorupski KA. 2013. Clinical characteristics
and outcome in dogs with splenic marginal zone lymphoma. Journal of Veterinary Internal Medicine 27:949-954.
（151）Okawa T, Hiraoka H, Wada Y, Baba K, Itamoto K, Mizuno T, Okuda M. 2012. Development of high-grade B-Cell lymphoma
concurrent with T-cell chronic lymphocytic leukemia in a dog. The Journal of Veterinary Medical Science 74:677-680.
（152）Olsson M, Frankowiack M, Tengvall K, Roosje P, Fall T, Ivansson E, Bergvall K, Hansson-Hamlin H, Sundberg K,
Hedhammar A, Lindblad-Toh K, Hammarström L. 2014. The dog as a genetic model for immunoglobulin A (IgA) deficiency:
identification of several breeds with low serum IgA concentrations. Veterinary Immunology and Immunopathology
160:255-259.
（153）大西堂文，猪熊 壽，大野耕一，添田晋吾，野口主宏，佐々木主計．2000. レーザー免疫比ろう法による健常犬および疾患犬における C- 反応性蛋白の測定．日本獣医師会雑誌 53:595-601.
（154）Perkins MC, Canfield P, Churcher RK, Malik R. 2004. Immune-mediated neutropenia suspected in five dogs. Australian

Veterinary Journal 82:52-57.
（155）Perryman LE. 2004. Molecular pathology of severe combined immunodeficiency in mice, horses, and dogs. Veterinary
Pathology 41:95-100.
（156）Peterson ME, Hurvitz AI, Leib MS, Cavanagh PG, Dutton RE 1984. Propylthiouracil- associated hemolytic anemia,
thrombocytopenia, and antinuclear antibodies in cats with hyperthyroidism. Journal of the American Veterinary Medical
Association 184:806-808.
（157）Piek C. 2017. Immune-mediated hemolytic anemias and other regenerative anemias. Textbook of Veterinary Internal
Medicine 8th ed. (Ettinger SJ, Feldman EC, Cote E eds), 829-837, Elsevier.
（158）Piek CJ, Brinkhof B, Teske E, Rothuizen J, Dekker A, Penning LC. 2011. High intravascular tissue factor expression indogs with idiopathic immune-mediated haemolytic anaemia. Veterinary Immunology and Immunopathology 144:346-354.
（159）Piek CJ, Junius G, Dekker A, Schrauwen E, Slappendel RJ, Teske E. 2008. Idiopathic immune-mediated hemolytic anemia:
treatment outcome and prognostic factors in 149 dogs. Journal of Veterinary Internal Medicine 22:366-373.
（160）Piek CJ, van Spil WE, Junius G, Dekker A. 2011. Lack of evidence of a beneficial effect of azathioprine in dogs treatedwith prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study. BMC Veterinary

Research 7:15.

第 章

49

11
（161）Plechner AJ. 1979. IgM deficiency in 2 Doberman Pinschers. Modern Veterinary Practice 60:150.
（162）Post JE, Noronha F, Rickard CG. 1970. Canine mast cell leukemia. Bibliotheca Haematologica 36:425-429.
（163）Postorino NC, Susaneck SJ, Withrow SJ et al. 1989. Singe agent therapy with adriamycin for canine lymphosarcoma.

Journal of the American Animal Hospital Association 25:221-225.
（164）Price GS, Armstrong PJ, McLeod DA, Babineau CA, Metcalf MR, Sellett LC. 1988. Evaluation of citrate-phosphatedextrose-adenine as a storage medium for packed canine erythrocytes. Journal of Veterinary Internal Medicine 2:126-132.
（165）Putsche JC, Kohn B. 2008. Primary immune-mediated thrombocytopenia in 30 dogs (1997-2003). Journal of theAmerican Animal Hospital Association 44:250-257.
（166）Rassnick KM, Moore AS, Russell DS, Northrup NC, Kristal O, Bailey DB, Flory AB, Kiselow MA, Intile JL. 2010. Phase II,
open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma. Journal of Veterinary Internal

Medicine 24:1528-1531.
（167）Rau SE, Burgess KE. 2017. A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate
to large cell gastrointestinal lymphoma (2006-2013). Veterinary and Comparative Oncology 15:1019-1028.
（168）Reguera MJ, Rabanal RM, Puigdemont A, Ferrer L. 2000. Canine mast cell tumors express stem cell factor receptor. The

American Journal of Dermatopathology 22:49-54.
（169）Richter MN. 1928. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. The American

Journal of Pathology 4:285-299.
（170）Ridyard AE, Shaw DJ, Milne EM. 2010. Evaluation of platelet activation in canine immune-mediated haemolytic anaemia.

Journal of Small Animal Practice 51:296-304.
（171）Robert HP. 2006. Lymphoid leukemia in dogs. Compendium 28:831-849.
（172）Rout ED, Burnett RC, Yoshimoto JA, Avery PR, Avery AC. 2019. Assessment of immunoglobulin heavy chain,immunoglobulin light chain, and T-cell receptor clonality testing in the diagnosis of feline lymphoid neoplasia. Veterinary
Clinical Pathology 48:45-58.
（173）Rozanski EA, Callan MB, Hughes D, Sanders N, Giger U. 2002. Comparison of platelet count recovery with use ofvincristine and prednisone or prednisone alone for treatment for severe immune-mediated thrombocytopenia in dogs.
Journal of the American Veterinary Medical Association 220:477-481.
（174）Saba CF, Thamm DH, Vail DM. 2007. Combination chemotherapy with L-asparaginase, lomustine, and prednisone forrelapsed or refractory canine lymphoma. Journal of Veterinary Internal Medicine 21:127-132.
（175）Sasaki K, Ma Z, Khatlani TS, Okuda M, Inokuma H, Onishi T. 2003. Evaluation of feline serum amyloid A (SAA) as an
inflammatory marker. Journal of Veterinary Medical Science 65:545-548.
（176）Sato M, Veir JK, Legare M, Lappin MR. 2017. A retrospective study on the safety and efficacy of leflunomide in dogs.

Journal of Veterinary Internal Medicine 31:1502-1507.
（177）Scott-Moncrieff JC, Treadwell NG, McCullough SM, Brooks MB. 2001. Hemostatic abnormalities in dogs with primary
immune-mediated hemolytic anemia. Journal of the American Animal Hospital Association 37:220-227.
（178）Scott-Moncrieff JC, Reagan WJ. 1997. Human intravenous immunoglobulin therapy. Seminars in Veterinary Medicine andSurgery (small Animal) 12:178-185.
（179）Setoguchi A, Sakai T, Okuda M, Minehata K, Yazawa M, Ishizaka T, Watari T, Nishimura R, Sasaki N, Hasegawa A,
Tsujimoto H. 2001. Aberrations of the p53 tumor suppressor gene in various tumors in dogs. American Journal of

Veterinary Research 62:433-439.
（180）下田哲也，白永伸行，渡辺雄志，野呂浩介，辻井宏文．1997. 猫の急性白血病 15 例の臨床病理．日本獣医師会雑誌
50:38-42.
（181）Shimoda T, Shiranaga N, Mashita T, Hasegawa A. 2000. A hematological study on thirteen cats with myelodysplastic
syndrome. The Journal of Veterinary Medical Science 62:59-64.
（182）Simon D, Moreno SN, Hirschberger J Moritz A, Kohn B, Neumann S, Jurina K, Scharvogel S, Schwedes C, Reinacher M,
Beyerbach M, Nolte I. 2008. Efficacy of a continuous, multiagent chemotherapy protocol versus a short-term single-agent

第 章

50

11

protocol in dogs with lymphoma. Journal of the American Veterinary Medical Association 232:879-885.
（183）Skorupski KA, Clifford CA, Paoloni MC, Lara-Garcia A, Barber L, Kent MS, LeBlanc AK, Sabhlok A, Mauldin EA, Shofer
FS, Couto CG, Sørenmo KU. 2007. CCNU for the treatment of dogs with histiocytic sarcoma. Journal of Veterinary Internal

Medicine 21:121-126.
（184）Smithson CW, Smith MM, Tappe J, Beaudin A, Bradley M. 2012. Multicentric oral plasmacytoma in 3 dogs. Journal of

Veterinary Dentistry 29:96-110.
（185）Sontas HB, Dokuzeylu B, Turna O, Ekici H. 2009. Estrogen-induced myelotoxicity in dogs: A review. The Canadian

Veterinary Journal 50:1054-1058.
（186）Sorenmo K, Overley B, Krick E, Ferrara T, LaBlanc A, Shofer F. 2010. Outcome and toxicity associated with a doseintensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases. Veterinary andComparative Oncology 8:196-208.
（187）Spangler WL, Kass PH. 1998. Pathologic and prognostic characteristics of splenomegaly in dogs due to fibrohistiocytic
nodules: 98 cases. Veterinary Pathology 35:488-498.
（188）Stein TJ, Pellin M, Steinberg H, Chun R. 2010. Treatment of feline gastrointestinal small-cell lymphoma with chlorambucil
and glucocorticoids. Journal of the American Animal Hospital Association 46:413-417.
（189）Stokol T, Blue JT, French TW, Idiopathic pure red cell aplasia and nonregenerative immune-mediated anemia in dogs: 43
cases (1988-1999). Journal of the American Veterinary Medical Association 216:1429-1436 (2000)（190）Stokol T, Blue JT, French TW. 2000. Idiopathic pure red cell aplasia and nonregenerative immune-mediated anemia in
dogs: 43 cases (1988-1999). Journal of the American Veterinary Medical Association 216:1429-1436.
（191）Sundburg CR, Belanger JM, Bannasch DL, Famula TR, Oberbauer AM. 2016. Gonadectomy effects on the risk of immune
disorders in the dog: a retrospective study. BMC Veterinary Research 12:278.
（192）Suter SE, Hamilton MJ, Sullivan EW, Venkataraman GM. 2015. Allogeneic hematopoietic cell transplantation in a dog withacute large granular lymphocytic leukemia. Journal of the American Veterinary Medical Association 246:994-997.
（193）Suter SE, Small GW, Seiser EL, Thomas R, Breen M, Richards KL. 2011. FLT3 mutations in canine acute lymphocytic
leukemia. BMC Cancer 11:38.
（194）Suzuki S, Ogino N, Mitsui I, Ito H, Kariya T. 2021. Anti-CD71 antibody immunohistochemistry in the diagnosis of acute
myeloid leukemia, subtype acute erythroid leukemia with erythroid dominance (AML M6-Er), in a retrovirus-negative cat.

Journal of Veterinary Diagnostic Investigation 33:87-94.
（195）Swann JW, Garden OA, Fellman CL, Glanemann B, Goggs R, LeVine DN, Mackin AJ, Whitley NT. 2019. ACVIM consensus
statement on the treatment of immune-mediated hemolytic anemia in dogs. Journal of Veterinary Internal Medicine
33:1141-1172.
（196）Swann JW, Szladovits B, Glanemann B. 2016. Demographic characteristics, survival and prognostic factors for mortality
in cats with primary immune-mediated hemolytic anemia. Journal of Veterinary Internal Medicine 30:147-156.
（197）Takahashi M, Tomiyasu H, Hotta E, Asada H, Fukushima K, Kanemoto H, Fujino Y, Ohno K, Uchida K, Nakayama H,
Tsujimoto H. 2014. Clinical characteristics and prognostic factors in dogs with histiocytic sarcomas in Japan. The Journal of

Veterinary Medical Science 76:661-666.
（198）Takahashi T, Otani I, Okuda M, Inoue M, Ito K, Sakai M, Koie H, Yamaya Y, Watari T, Sato T, Kanayama K, Tokuriki M.
2007. Malignant transformation of T-cell large granular lymphocyte leukemia in a dog. The Journal of Veterinary Medical

Science 69:677-681.
（199）Tamamoto T, Ohno K, Takahashi M, Nakashima K, Fujino Y, Tsujimoto H. 2013. Serum amyloid A as a prognostic marker
in cats with various diseases. Journal of Veterinary Diagnostic Investigation 25:428-432.
（200）Tamura Y, Nagamoto T, Segawa K, Neo S, Igarashi H, Hisasue M. 2020. Successful treatment and long-term follow up
of idiopathic immune-mediated polyarthritis with mycophenolate mofetil in a cat. Journal of Feline Medicine and Surgery

Open Reports 6(2):2055116920963995.
（201）Tani A, Tomiyasu H, Ohmi A, Ohno K, Tsujimoto H. 2020. Clinical and clinicopathological features and outcomes of

第 章

51

11
Miniature Dachshunds with bone marrow disorders. The Journal of Veterinary Medical Science 82:771-778.
（202）Tani A, Tomiyasu H, Uchikai T, Matsumoto Y, Ishihara G, Goto YY, Ohno K, Tsujimoto H. 2019. Gene mutations detectedin Miniature Dachshunds diagnosed with myelodysplastic syndrome in Japan. Journal of Veterinary Internal Medicine
33:2481.
（203）Tasca S, Carli E, Caldin M, Menegazzo L, Furlanello T, Gallego LS. 2009. Hematologic abnormalities and flow cytometricimmunophenotyping results in dogs with hematopoietic neoplasia: 210 cases (2002-2006). Veterinary Clinical Pathology
38:2-12.
（204）Tasker S. 2010. Haemotropic mycoplasmas: what’s their real significance in cats? Journal of Feline Medicine and Surgery
12:369-381.
（205）Terry A, Callanan JJ, Fulton R, Jarrett O, Neil JC. 1995. Molecular analysis of tumours from feline immunodeficiency virus(FIV)-infected cats: an indirect role for FIV?. International Journal of Cancer 61:227-232.
（206）Teske E, van Straten G, van Noort R, Rutteman GR. 2002. Chemotherapy with cyclophosphamide, vincristine, andprednisolone (COP) in cats with malignant lymphoma: new results with an old protocol. Journal of Veterinary Internal

Medicine 16:179-186.
（207）Thomas R, Smith KC, Gould R, Gower SM, Binns MM, Breen M. 2001. Molecular cytogenetic analysis of a novel highgrade canine T-lymphoblastic lymphoma demonstrating co-expression of CD3 and CD79a cell markers. Chromosome

Research 9:649-657.
（208）Thomas R, Smith KC, Ostrander EA, Galibert F, Breen M.. 2003. Chromosome aberrations in canine multicentric
lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. British Journal of Cancer
89:1530-1537.
（209）通山 薫，張替秀郎．2018. 血液細胞アトラス 第 6 版，文光堂．
（210）Tomiyasu H, Doi A, Chambers JK, Goto-Koshino Y, Ohmi A, Ohno K, Tsujimoto H. 2018. Clinical and clinicopathologicalcharacteristics of acute lymphoblastic leukaemia in six cats. Journal of Small Animal Practice 59:742-746.
（211）Tsang M, Parikh SA. 2017. A concise review of autoimmune cytopenias in chronic lymphocytic leukemia. Current

Hematologic Malignancy Reports 12:29-38.
（212）Usher SG, Radford AD, Villiers EJ, Blackwood L. 2009. RAS, FLT3, and C-KIT mutations in immunophenotyped canine
leukemias. Experimental Hematology 37:65-77.
（213）Valdés-Martínez A, Cianciolo R, Mai W. 2007. Association between renal hypoechoic subcapsular thickening andlymphosarcoma in cats. Veterinary Radiology & Ultrasound 48:357-360.
（214）Valli VE, Jacobs RM, Parodi AL, et al. 2002. Histological Classification of Hematopoietic Tumors of Domestic Animals,
Armed Forces Institute of Pathology.
（215）Valli VE, San Myint S, Barthel A, Bienzle D, Caswell J, Colbatzky F, Durham A, Ehrhart EJ, Johnson Y, Jones C, Kiupel M,
Labelle P, Lester S, Miller M, Moore P, Moroff S, Roccabianca P, Ramos-Vara J, Ross A, Scase T, Tvedten H, Vernau W. 2011.
Classification of canine malignant lymphomas according to the World Health Organization criteria. Veterinary Pathology
48:198-211.
（216）Valli VE, Vernau W, de Lorimier LP, Graham PS, Moore PF. 2006. Canine indolent nodular lymphoma. Veterinary Pathology
43:241-256.
（217）Vargo CL, Taylor SM, Haines DM. 2007. Immune mediated neutropenia and thrombocytopenia in 3 giant schnauzers. The

Canadian Veterinary Journal 48:1159-1163.
（218）Veldhoen N, Stewart J, Brown R, Milner J. 1998. Mutations of the p53 gene in canine lymphoma and evidence for germline p53 mutations in the dog. Oncogene 16:249-255.
（219）Vélez A, García-Aranda JM, Moreno JC. 1999. Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic
factor?. Journal of the European Academy of Dermatology and Venereology 12:243-244.
（220）Vernau W, Moore PF. 1999. An immunophenotypic study of canine leukemias and preliminary assessment of clonality bypolymerase chain reaction. Veterinary Immunology and Immunopathology 69:145-164.

第 章

52

11

（221）Wang Q, Zhang W, He G, Sha H, Quan Z. 2016. Method for in vitro differentiation of bone marrow mesenchymal stem
cells into endothelial progenitor cells and vascular endothelial cells. Molecular Medicine Reports 14:5551-5555.
（222）Wardrop KJ, Birkenheuer A, Blais MC, Callan MB, Kohn B, Lappin MR, Sykes J. 2016. Update on canine and feline blood
donor screening for blood-borne pathogens. Journal of Veterinary Internal Medicine 30:15-35.
（223）Weeden AL, Taylor KR, Terrell SP, Gallagher AE, Wamsley HL. 2016. Suspected myelodysplastic/myeloproliferative
neoplasm in a feline leukemia virus-negative cat. Veterinary Clinical Pathology 45:584-593.
（224）Weinkle TK, Center SA, Randolph JF, Warner KL, Barr SC, Erb HN. 2005. Evaluation of prognostic factors, survival rates,
and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002). Journal of the American
Veterinary Medical Association 226:1869-1880.
（225）Weiss DJ. 2002. Application of flow cytometric techniques to veterinary clinical hematology. Veterinary Clinical Pathology
31:72-82.
（226）Weiss DJ. 2001. Flow cytometric and immunophenotypic evaluation of acute lymphocytic leukemia in dog bone marrow.

Journal of Veterinary Internal Medicine 15:589-594.
（227）Weiss DJ. 2002. Primary pure red cell aplasia in dogs: 13 cases (1996-2000). Journal of the American Veterinary Medical
Association 221:93-95.
（228）Weiss DJ. 2005. Bone marrow necrosis in dogs: 34 cases (1996-2004). Journal of the American Veterinary Medical
Association 227:263-267.
（229）Weiss DJ. 2007. Evaluation of antineutrophil IgG antibodies in persistently neutropenic dogs. Journal of Veterinary

Internal Medicine 21:440-444.
（230）Weiss DJ. 2008. Bone marrow pathology in dogs and cats with non-regenerative immune-mediated haemolytic anaemia
and pure red cell aplasia. Journal of Comparative Pathology 138:46-53.
（231）Weiss DJ, Smith SA. 2002. A retrospective study of 19 cases of canine myelofibrosis. Journal of Veterinary Internal

Medicine 16:174-178.
（232）Weiss DJ, Stockham SL, Willard MD, Schirmer RG. 1982. Transient erythroid hypoplasia in the dog: report of five cases.

Journal of the American Animal Hospital Association 18:353-359.
（233）Weiss DJ. 2003. New insights into the physiology and treatment of acquired myelodysplastic syndromes and aplastic
pancytopenia. Veterinary Clinics of North America: Small Animal Practice 33:1317-1334.
（234）Weiss DJ. 2005. Recognition and classification of dysmyelopoiesis in the dog. Journal of Veterinary Internal Medicine 19:
147-154.
（235）Weiss DJ. 2006. Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005). Journal of the American Veterinary Medical
Association 228:893-897.
（236）Wiinberg B, Jensen AL, Johansson PI, Rozanski E, Tranholm M, Kristensen AT. 2008. Thromboelastographic evaluation ofhemostatic function in dogs with disseminated intravascular coagulation. Journal of Veterinary Internal Medicine 22:357365.
（237）Willi B, Novacco M, Meli M, Wolf-Jäckel G, Boretti F, Wengi N, Lutz H, Hofmann-Lehmann R. 2010. Haemotropic
mycoplasmas of cats and dogs: transmission, diagnosis, prevalence and importance in Europe. Schweizer Archiv fürTierheilkunde 152: 237-244.
（238）Williams MJ, Avery AC, Lana SE, Hillers KR, Bachand AM, Avery PR. 2008. Canine lymphoproliferative diseasecharacterized by lymphocytosis: immunophenotypic markers of prognosis. Journal of Veterinary Internal Medicine 22:596601.
（239）Wondratschek C, Weingart C, Kohn B. 2010. Primary immune-mediated thrombocytopenia in cats. Journal of theAmerican Animal Hospital Association 46:12-19.
（240）Woolcock A, Scott-Moncrieff JCR. 2020. Pathogenesis of Immune-Mediated Disorders. Small Animal Internal Meidicine
6th ed. (Nelson RW, Couto CG eds), 1212-1214, Elsevier.
（241）Woolcock A, Scott-Moncrieff JCR. 2020. Common immune-mediated diseases. Small Animal Internal Meidicine 6th ed.

第 章

53

11
(Nelson RW, Couto CG eds), 1231-1256, Elsevier.
（242）Woolcock A, Scott-Moncrieff JCR. 2020. Treatment of primary immune-mediated diseases. Small Animal Internal
Meidicine 6th ed. (Nelson RW, Couto CG eds), 1220-1230, Elsevier.
（243）Workman HC, Vernau W. 2003. Chronic lymphocytic leukemia in dogs and cats : the veterinary perspective. Veterinary

Clinics of North America: Small Animal Practice 33:1379-1399.
（244）Wright ZM, Rogers KS, Mansell J. 2008. Survival data for canine oral extramedullary plasmacytomas: a retrospective
analysis (1996-2006). Journal of the American Animal Hospital Association 44:75-81.
（245）Yang TJ. 1987. Gray collie syndrome. Journal of the American Veterinary Medical Association 191:390-391.
（246）Yearley JH, Stanton C, Olivry T, Dean GA. 2007. Phagocytic plasmacytoma in a dog. Veterinary Clinical Pathology. 36:293296.
（247）Zandecki M, Genevieve F, Gerard J, Godon A. 2007. Spurious counts and spurious results on haematology analysers: a
review. Part II: white blood cells, red blood cells, haemoglobin, red cell indices and reticulocytes. International Journal ofLaboratory Hematology 29:21-41.
（248）Zoia A, Drigo M. 2017. Association between pancreatitis and immunemediated haemolytic anaemia in cats: a crosssectional study. Journal of Comparative Pathology 156:384-388.
（249）Zulty JC, Kociba GJ. 1990. Cold agglutinins in cats with haemobartonellosis. Journal of the American Veterinary Medical
Association 196:907-910.
（250）Zwingenberger AL, Marks SL, Baker TW, Moore PF. 2010. Ultrasonographic evaluation of the muscularis propria in catswith diffuse small intestinal lymphoma or inflammatory bowel disease. Journal of Veterinary Internal Medicine 24:289-292.
参考図書
Greene CE ed. 2011. Infectious Diseases of the Dog and Cat 4th ed., Saunders.